Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial
Authors
Keywords
Severe eosinophilic asthma, Cessation of treatment, Asthma control, Blood eosinophils
Journal
Allergy Asthma and Clinical Immunology
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-10
DOI
10.1186/s13223-019-0348-z
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.